85-1433-82 [取扱停止]Epstein Barr Virus (EBV), Viral Capsid Antigen p23, aa1-162, Recombinant 1mg E3440-27
特徴
- EBV p23 is a viral late complex associated with virion particles and consists of two gene products, BFRF3 and BLRF2.
- Contains EBV(HHV-4) p23 fragment, amino acids: (1-162).
- Applications:Suitable for use in Western Blot and ELISA. Other applications have not been tested.
- Recommended Dilutions:Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:1mg
- Source Antigen:Recombinant (E. coli)
- Grade:Highly Purified
- Purity:≥95% by10% PAGE. Chromatographically purified.
- Form:Supplied as a liquid in 25mM glycine, pH 9.6, 50% glycerol.
- Specificity:Immunoreactive with sera of EBV-infected individuals.
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





